Key Factors based on World Smoking Cessation Market 2023 - PowerPoint PPT Presentation

Loading...

PPT – Key Factors based on World Smoking Cessation Market 2023 PowerPoint presentation | free to download - id: 842fab-OTBmN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Key Factors based on World Smoking Cessation Market 2023

Description:

Get a sample brochure @ Pharmaceutical, Commercial & Strategic Developments in the Global Smoking Cessation Market 2013-2023 In April 2013 the US Food & Drug Agency (FDA) announced its plan to relax rules regarding the use and labelling of over-the-counter nicotine replacement therapies. On April 1st 2013, FDA Commissioner Margaret A. Hamburg M.D. stated, “The agency heard from several public health groups that the labelling for OTC NRT products may stop consumers who are trying to quit smoking from using them. The FDA hopes the recommended changes will allow more people to use these products effectively for smoking cessation and that tobacco dependence will decline in this country.” Will new changes increase take-up of smoking cessation products? This report tells you. – PowerPoint PPT presentation

Number of Views:25

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Key Factors based on World Smoking Cessation Market 2023


1
Smoking Cessation - Data, Analysis Forecasts to
2023
Published Date 04 October, 2013 No of
Pages 101 Single User Price 2500
Global Smoking Cessation Market is forecast to
reach 4.4bn in 2023
Click Here To Check Complete Report
2
  • Smoking Cessation - Data, Analysis Forecasts
    till 2023'
  • Pharmaceutical, Commercial Strategic
    Developments in the Global Smoking Cessation
    Market 2013-2023
  • In April 2013 the US Food Drug Agency (FDA)
    announced its plan to relax rules regarding the
    use and labelling of over-the-counter nicotine
    replacement therapies.
  • On April 1st 2013, FDA Commissioner Margaret A.
    Hamburg M.D. stated, The agency heard from
    several public health groups that the labelling
    for OTC NRT products may stop consumers who are
    trying to quit smoking from using them.

3
  • The FDA hopes the recommended changes will allow
    more people to use these products effectively for
    smoking cessation and that tobacco dependence
    will decline in this country. Will new changes
    increase take-up of smoking cessation products?
    This report tells you.
  • The global smoking cessation market is forecast
    to reach 4.4bn in 2023, but what will it be this
    year? Next year? And in 5 years time?
  • New smoking cessation report outlines the key
    factors affecting the market across the forecast
    period 2013-2023. The report outlines essential
    drivers and restraints in all key global
    geographies.
  • Nicoderm and Habitrol are the primary NRT
    products on the market, accounting for over 80
    of the global NRT market revenue in 2013.
  • Bupropion and Varenicline are the major products
    in the prescription drug segment of the smoking
    cessation market. But what are the 5 key drivers
    of the global smoking cessation market?

4
  • Increased health care / health education in many
    geographies
  • Adoption of smoking cessation products onto
    health insurance policies
  • Increasing number of smoking cessation products
    emerging onto the market
  • Emergence of e-cigarettes onto the global market
  • Over 1bn smokers worldwide
  • This report analysis your market, in key
    geographic segments explains in which direction
    each key market will grow across the next 10
    years, and why. Can you afford to ignore this
    report?
  • Key challenges for you your competition
  • The key challenges that must be faced in the
    smoking cessation market include a weak RD
    pipeline, off putting side effects affecting key
    smoking cessation drugs and the challenge of
    multiple e-cigarette brands encroaching the
    traditional NRT marketplace.
  • Only by ordering this in-depth exclusive report
    will you have full access to the unique findings.
    This information is not available anywhere else.
    Find full details of these approved drugs
    alongside key cancer drugs in their testing
    phases in this new GMR Data report.

5
  • This report also breaks down the market in terms
    of current smoking cessation drugs and products
    that occupy the market at present examining the
    key prescription and OTC drugs that drive the
    market.
  • In addition to this crucial information this
    report offers analysis and opinion on current RD
    in the smoking cessation sector alongside in
    depth analysis of the emerging, global
    e-cigarette market. 
  • Discover exactly what the industry leaders are
    doing TODAY
  • Smoking Cessation - Data, Analysis Forecasts
    to 2023 we analyses the key cessation products
    and drugs in the market currently and how they
    will perform across the next decade.
  • Our study focuses on the individual revenues of
    the top Smoking Cessation products. With variable
    patents and the threat of generics, how will
    these key products fare across the next decade?
    ONLY THIS UNIQUE REPORT WILL TELL YOU

Make an Inquiry Before Buying
6
  • We also include analysis of key NRT (Nicotine
    Replacement Therapies such as NicoDerm CQ
    Nicotrol Habitrol (Nicotinell) and Nicorette.
    Also analysed are the prescription drugs for
    smoking cessation, such as Chantix (by Pfizer)
    Varenicline and Zyban / Wellbutrin (by GSK)
    bupropion.
  • With assessment of the leading players in smoking
    cessation including Pfizer GlaxoSmithKline
    (GSK) Novartis Johnson Johnson (JJ)
    Perrigo Sophomore and Extab plus 22nd Century
    Group, Inc.
  • PLUS In-depth country analysis Discover which
    countries and regions will drive the smoking
    cessation drugs market to 2023?
  • Prescription drugs in the smoking cessation have
    proved popular and, to some extent, effective.
    However, side effects and increasingly severe FDA
    warnings have put some potential customers off.
    What this means is that there is still space in
    the market for new pipeline drugs, with fewer
    side effects and greater efficacy.

Download Sample Brochure
7
  • But how will these prescription markets develop?
    This report will tell you - TODAY
  • Industry information sourced exclusively for this
    report. This information is not available
    anywhere else
  • Utilizing primary and secondary research sources,
    GMR Data have interviewed leading smoking
    cessation specialists within big pharma, RD,
    wholesalers, distributors, marketers and key
    organizations. From these interviews we have
    selected original, exclusive, transcribed
    interviews with leading specialists in their
    field This information is not available
    anywhere else.
  • This report is the single tool to equip you with
    the latest trends in all regional markets and why
    all stakeholders demand development of Smoking
    Cessation products. This report will arm you with
    all you and your company require to develop,
    price, launch and market a smoking cessation
    product.
  • With over 100 pages, and over 85 pages of
    charts, tables, figures and graphs, this
    dedicated specialist report will ensure you
    remain equipped and fully informed, to succeed in
    this competitive market.

8
Smoking Cessation - Data, Analysis Forecasts to
2023
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the World Smoking Cessation Market and future
opportunities are provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.
com www.marketintelreports.com
Click here to order a copy of World Smoking
Cessation Market Report
About PowerShow.com